Additionally, the upstream region of γ-globin promoter which includes transcriptional factor binding sites, such as BCL11A, LRF, KLF1, and GATA1 are also possible base-editing targets for HbF induction to treat SCD and β-thalassemia [112,113,114]. This evidence concerns the gene BCL11A and Schnyder corneal dystrophy.